213 related articles for article (PubMed ID: 9642442)
1. Static DNA cytometry as a diagnostic aid in effusion cytology: II. DNA aneuploidy for identification of neoplastic cells in equivocal effusions.
Motherby H; Nadjari B; Remmerbach T; Marcy T; Pomjanskaja N; Müller W; Knops K; Häussinger D; Strauer BE; Böcking A
Anal Quant Cytol Histol; 1998 Jun; 20(3):162-8. PubMed ID: 9642442
[TBL] [Abstract][Full Text] [Related]
2. Static DNA cytometry as a diagnostic aid in effusion cytology: I. DNA aneuploidy for identification and differentiation of primary and secondary tumors of the serous membranes.
Motherby H; Marcy T; Hecker M; Ross B; Nadjari B; Auer H; Müller KM; Häussinger D; Strauer BE; Böcking A
Anal Quant Cytol Histol; 1998 Jun; 20(3):153-61. PubMed ID: 9642441
[TBL] [Abstract][Full Text] [Related]
3. Role of DNA flow cytometry and image cytometry on effusion fluid.
Saha I; Dey P; Vhora H; Nijhawan R
Diagn Cytopathol; 2000 Feb; 22(2):81-5. PubMed ID: 10649516
[TBL] [Abstract][Full Text] [Related]
4. Image cytometry: an aid for cytological diagnosis of pleural effusions.
Osterheld MC; Liette C; Anca M
Diagn Cytopathol; 2005 Mar; 32(3):173-6. PubMed ID: 15690335
[TBL] [Abstract][Full Text] [Related]
5. Immunocytochemistry and DNA-image cytometry in diagnostic effusion cytology. II. Diagnostic accuracy in equivocal smears.
Motherby H; Friedrichs N; Kube M; Nadjari B; Knops K; Donner A; Baschiera B; Dalquen P; Böcking A
Anal Cell Pathol; 1999; 19(2):59-66. PubMed ID: 10746435
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic DNA-flow- vs. -image-cytometry in effusion cytology.
Motherby H; Pomjanski N; Kube M; Boros A; Heiden T; Tribukait B; Böcking A
Anal Cell Pathol; 2002; 24(1):5-15. PubMed ID: 12122279
[TBL] [Abstract][Full Text] [Related]
7. 9p21 Deletion in the diagnosis of malignant mesothelioma in serous effusions additional to immunocytochemistry, DNA-ICM, and AgNOR analysis.
Onofre FB; Onofre AS; Pomjanski N; Buckstegge B; Grote HJ; Böcking A
Cancer; 2008 Jun; 114(3):204-15. PubMed ID: 18306350
[TBL] [Abstract][Full Text] [Related]
8. Early diagnosis of mesothelioma in serous effusions using AgNOR analysis.
Pomjanski N; Motherby H; Buckstegge B; Knops K; Rohn BL; Böcking A
Anal Quant Cytol Histol; 2001 Apr; 23(2):151-60. PubMed ID: 11332082
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic analysis of effusions from malignant mesothelioma. A diagnostic adjunct to cytology.
Granados R; Cibas ES; Fletcher JA
Acta Cytol; 1994; 38(5):711-7. PubMed ID: 8091903
[TBL] [Abstract][Full Text] [Related]
10. Role of DNA flow cytometry and immunocytochemical analysis in diagnosis of malignant effusions.
Kundu R; Handa U; Mohan H
Diagn Cytopathol; 2012 Oct; 40(10):887-92. PubMed ID: 21485027
[TBL] [Abstract][Full Text] [Related]
11. Additional techniques in serous effusions.
Hanselaar AG
Anal Cell Pathol; 2002; 24(1):1-4. PubMed ID: 12216539
[TBL] [Abstract][Full Text] [Related]
12. Value of DNA analysis in addition to cytological testing in the diagnosis of malignant pleural effusions.
Rodríguez de Castro F; Molero T; Acosta O; Julià-Serdà G; Caminero J; Cabrera P; Carrillo T
Thorax; 1994 Jul; 49(7):692-4. PubMed ID: 8066565
[TBL] [Abstract][Full Text] [Related]
13. Adaptation of a commercial fluorescent in situ hybridization test to the diagnosis of malignant cells in effusions.
Flores-Staino C; Darai-Ramqvist E; Dobra K; Hjerpe A
Lung Cancer; 2010 Apr; 68(1):39-43. PubMed ID: 19523712
[TBL] [Abstract][Full Text] [Related]
14. Telomerase activity analyzed with TRAP in situ provides additional information in effusions remaining equivocal after immunocytochemistry and hyaluronan analysis.
Adell E; Dejmek A
Diagn Cytopathol; 2014 Dec; 42(12):1051-7. PubMed ID: 24692425
[TBL] [Abstract][Full Text] [Related]
15. Routine DNA cytometry of benign and malignant pleural effusions by means of the remote quantitation server Euroquant: a prospective study.
Kayser K; Blum S; Beyer M; Haroske G; Kunze KD; Meyer W
J Clin Pathol; 2000 Oct; 53(10):760-4. PubMed ID: 11064669
[TBL] [Abstract][Full Text] [Related]
16. Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas.
Sriram KB; Relan V; Clarke BE; Duhig EE; Windsor MN; Matar KS; Naidoo R; Passmore L; McCaul E; Courtney D; Yang IA; Bowman RV; Fong KM
BMC Cancer; 2012 Sep; 12():428. PubMed ID: 23009708
[TBL] [Abstract][Full Text] [Related]
17. DNA aneuploidy as a specific marker of neoplastic cells in FNAB of the thyroid.
Nadjari B; Motherby H; Pooschke T; Pooschke S; Gabbert HE; Simon D; Röher HD; Feldkamp J; Tharandt L; Böcking A
Anal Quant Cytol Histol; 1999 Dec; 21(6):481-8. PubMed ID: 10626017
[TBL] [Abstract][Full Text] [Related]
18. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
Friedman MT; Gentile P; Tarectecan A; Fuchs A
Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
[TBL] [Abstract][Full Text] [Related]
19. Measurement of cellular DNA content as an adjunct to diagnostic cytology in malignant effusions.
Hedley DW; Philips J; Rugg CA; Taylor IW
Eur J Cancer Clin Oncol; 1984 Jun; 20(6):749-52. PubMed ID: 6540177
[TBL] [Abstract][Full Text] [Related]
20. The value of exfoliative cell cytology in the diagnosis of exudative pleural effusions.
Tetikkurt C; Yılmaz N; Tetikkurt S; Gundogdu Ş; Disci R
Monaldi Arch Chest Dis; 2018 Sep; 88(3):944. PubMed ID: 30203633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]